Table 3.
Group | Before modeling | After modeling | After treatment |
---|---|---|---|
Control | 3.25 ± 0.67 | 3.55 ± 0.45 | 3.58 ± 0.62 |
Model | 3.58 ± 0.65 | 6.40 ± 0.28* | 6.35 ± 0.36* |
Baicalin | 3.55 ± 0.36 | 6.32 ± 0.45* | 5.28 ± 0.39# |
Berberine | 3.64 ± 0.45 | 6.25 ± 0.54* | 4.38 ± 0.36# |
Mixture | 3.25 ± 0.35 | 6.30 ± 0.25* | 5.06 ± 0.28# |
Nanoparticles | 3.42 ± 0.58 | 6.35 ± 0.50* | 3.82 ± 0.45# |
ANOVA with the post hoc test was used to calculate the significance of the differences, * and # represents P < 0.05 compared with the control and model group, respectively. The results are expressed as the mean ± S.D.